指南与共识泌尿生殖MRUS

意大利前列腺活检小组:2016年更新指南要点。

Italian Prostate Biopsies Group: 2016 Updated Guidelines Insights.
指南 / 共识 · Anticancer Res · 2017-01-01

目的:根据近期最佳文献证据,概述意大利前列腺活检小组的更新指南。材料与方法:由14名选自意大利的泌尿外科、病理科和放射科专家组成的小组,对2012-2015年出现的新数据进行系统评价。专家们通过使用Medline、EMBASE和Cochrane Library数据库进行检索,收集了以英语发表的文献文章。…

要点

  • mpMRI PI-RADS≥4时强烈推荐初次前列腺活检。
  • 既往活检阴性者强烈推荐使用mpMRI。
  • 每次活检至少取12针,并加可疑区域靶向穿刺。

核心结论

  • 指南推荐PSA>10 ng/ml、直肠指检异常或mpMRI PI-RADS≥4时强烈推荐初次前列腺活检。
  • mpMRI仅强烈推荐用于既往活检阴性的患者。
  • 每次至少取12针并加靶向(融合或认知)穿刺可疑区域。

研究设计与样本

  • 指南由意大利前列腺活检组制定,14名意大利泌尿外科、病理和放射科专家参与。
  • 系统检索2012至2015年Medline、EMBASE和Cochrane Library数据库的英文文献。
  • 采用GRADE框架系统评价证据等级并给出推荐。

诊断标准与关键数值

  • 初次前列腺活检强烈推荐条件:PSA>10 ng/ml、直肠指检异常或mpMRI PI-RADS≥4。
  • mpMRI仅在既往活检阴性患者中强烈推荐使用。
  • 每次活检至少取12针,并加靶向(融合或认知)穿刺可疑区域。
  • 饱和穿刺在所有情况下均为可选。
  • 报告前列腺活检结果时建议附加Gleason分级分组。

临床应用与阅片要点

  • 报告前列腺活检结果时建议附加Gleason分级分组。
  • 减少感染并发症的最佳策略仍有争议,现有减少感染的工具目前较弱。

局限性

  • 减少感染并发症的最佳策略仍有争议,现有减少感染的工具目前较弱。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

AIM: To present a summary of the updated guidelines of the Italian Prostate Biopsies Group following the best recent evidence of the literature.

MATERIALS AND METHODS: A systematic review of the new data emerging from 2012-2015 was performed by a panel of 14 selected Italian experts in urology, pathology and radiology. The experts collected articles published in the English-language literature by performing a search using Medline, EMBASE and the Cochrane Library database. The articles were evaluated using a systematic weighting and grading of the level of the evidence according to the Grading of Recommendations Assessment, Development and Evaluation framework system.

RESULTS: An initial prostate biopsy is strongly recommended when i) prostate specific antigen (PSA) >10 ng/ml, ii) digital rectal examination is abnormal, iii) multiparametric magnetic resonance imaging (mpMRI) has a Prostate Imaging Reporting and Data System (PIRADS) ≥4, even if it is not recommended. The use of mpMRI is strongly recommended only in patients with previous negative biopsy. At least 12 cores should be taken in each patient plus targeted (fusion or cognitive) biopsies of suspicious area (at mpMRI or transrectal ultrasound). Saturation biopsies are optional in all settings. The optimal strategy for reducing infection complications is still a controversial topic and the instruments to reduce them are actually weak. The adoption of Gleason grade groups in adjunction to the Gleason score when reporting prostate biopsy results is advisable.

CONCLUSION: These updated guidelines and recommendations are intended to assist physicians and patients in the decision-making regarding when and how to perform a prostatic biopsy.

来源:Anticancer Res,查看原文。版权归原作者所有。

引用

  1. Fandella A, Scattoni V, Galosi A, et al. Italian Prostate Biopsies Group: 2016 Updated Guidelines Insights. Anticancer Res. 2017. PMID: 28179286

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。